Trojani, A., Pungolino, E., Rossi, G., D'Adda, M., Lodola, M., Dal Molin, A., et al. (2018). Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, United States, Orlando, FL [10.1182/blood-2018-99-112188].

Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment

Cairoli R
2018

paper
Hematology
English
60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018
2018
2018
132
S1
5122
none
Trojani, A., Pungolino, E., Rossi, G., D'Adda, M., Lodola, M., Dal Molin, A., et al. (2018). Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, United States, Orlando, FL [10.1182/blood-2018-99-112188].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409412
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact